1. 44 Body composition may be prognostic and predictive of clinical outcomes in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI). (10th December 2020) Authors: Martini, Dylan; Anders Olsen, T; Goyal, Subir; Liu, Yuan; Evans, Sean; Magod, Benjamin; Brown, Jacqueline; Yantorni, Lauren; Russler, Greta; Caulfield, Sarah; Goldman, Jamie; Nazha, Bassel; Harris, Wayne; Kucuk, Omer; Carthon, Bradley; Master, Viraj; Bilen, Mehmet Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 44 Body composition may be prognostic and predictive of clinical outcomes in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI). (9th November 2020) Authors: Martini, Dylan; Anders Olsen, T; Goyal, Subir; Liu, Yuan; Evans, Sean; Magod, Benjamin; Brown, Jacqueline; Yantorni, Lauren; Russler, Greta; Caulfield, Sarah; Goldman, Jamie; Nazha, Bassel; Harris, Wayne; Kucuk, Omer; Carthon, Bradley; Master, Viraj; Bilen, Mehmet Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 637 Immune-related adverse events (irAEs) may indicate a favorable prognosis in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI). (10th December 2020) Authors: Martini, Dylan; Evans, Sean; Goyal, Subir; Liu, Yuan; Anders Olsen, T; Magod, Benjamin; Brown, Jacqueline; Yantorni, Lauren; Russler, Greta; Caulfield, Sarah; Goldman, Jamie; Nazha, Bassel; Harris, Wayne; Master, Viraj; Kucuk, Omer; Carthon, Bradley; Bilen, Mehmet Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 223 Racial differences in outcomes for metastatic renal cell carcinoma (mRCC) patients managed on immune-checkpoint inhibitor (ICI) therapy. (9th November 2020) Authors: Anders Olsen, T; Martini, Dylan; Goyal, Subir; Liu, Yuan; Evans, Sean; Magod, Benjamin; Brown, Jacqueline; Yantorni, Lauren; Russler, Greta; Caulfield, Sarah; Goldman, Jamie; Nazha, Bassel; Harris, Wayne; Master, Viraj; Kucuk, Omer; Carthon, Bradley; Bilen, Mehmet Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 255 Efficacy of sequential immune checkpoint inhibition (ICI) in patients with genitourinary malignancies. (9th November 2020) Authors: Evans, Sean; Martini, Dylan; Magod, Benjamin; Olsen, Timothy; Brown, Jacqueline; Yantorni, Lauren; Ravindranathan, Deepak; Russler, Greta; Caulfield, Sarah; Goldman, Jamie; Nazha, Bassel; Harris, Wayne; Master, Viraj; Kucuk, Omer; Carthon, Bradley; Bilen, Mehmet Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 45 Body composition as a predictive and prognostic biomarker in advanced urothelial carcinoma (UC) patients treated with immune checkpoint inhibitors (ICI). (9th November 2020) Authors: Martini, Dylan; Shabto, Julie; Goyal, Subir; Liu, Yuan; Anders Olsen, T; Evans, Sean; Magod, Benjamin; Ravindranathan, Deepak; Brown, Jacqueline; Yantorni, Lauren; Russler, Greta; Caulfield, Sarah; Goldman, Jamie; Nazha, Bassel; Joshi, Shreyas; Kissick, Haydn; Ogan, Kenneth; Harris, Wayne; Kucuk,... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 223 Racial differences in outcomes for metastatic renal cell carcinoma (mRCC) patients managed on immune-checkpoint inhibitor (ICI) therapy. (9th November 2020) Authors: Anders Olsen, T; Martini, Dylan; Goyal, Subir; Liu, Yuan; Evans, Sean; Magod, Benjamin; Brown, Jacqueline; Yantorni, Lauren; Russler, Greta; Caulfield, Sarah; Goldman, Jamie; Nazha, Bassel; Harris, Wayne; Master, Viraj; Kucuk, Omer; Carthon, Bradley; Bilen, Mehmet Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical Outcomes and Racial Disparities in Metastatic Hormone‐Sensitive Prostate Cancer in the Era of Novel Treatment Options. (29th June 2021) Authors: Smith, Katherine Emilie Rhoades; Brown, Jacqueline Theresa; Wan, Limeng; Liu, Yuan; Russler, Greta; Yantorni, Lauren; Caulfield, Sarah; Lafollette, Jennifer; Moore, Melvin; Kucuk, Omer; Carthon, Bradley; Nazha, Bassel; Bilen, Mehmet Asim Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: 956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options. (29th June 2021) Authors: Smith, Katherine Emilie Rhoades; Brown, Jacqueline Theresa; Wan, Limeng; Liu, Yuan; Russler, Greta; Yantorni, Lauren; Caulfield, Sarah; Lafollette, Jennifer; Moore, Melvin; Kucuk, Omer; Carthon, Bradley; Nazha, Bassel; Bilen, Mehmet Asim Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: 956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗